H.R. 1429: Scleroderma Research and Awareness Act of 2013

Introduced:
Apr 09, 2013
Status:
Referred to Committee on Apr 09, 2013
Prognosis
0% chance of being enacted
Track this bill

This bill was assigned to a congressional committee on April 9, 2013, which will consider it before possibly sending it on to the House or Senate as a whole.

Introduced
Apr 09, 2013
Reported by Committee
Passed House
Passed Senate
Signed by the President
 
Sponsor
Lois Capps
Representative for California's 24th congressional district
Party
Democrat
Text
Read Text »
Last Updated
Apr 09, 2013
Length
3 pages
Related Bills
H.R. 1672 (112th) was a previous version of this bill.

Referred to Committee
Last Action: May 02, 2011

 
Full Title

To expand the research and awareness activities of the National Institute of Arthritis and Musculoskeletal and Skin Diseases and the Centers for Disease Control and Prevention with respect to scleroderma, and for other purposes.

Summary

No summaries available.

 
Prognosis

3% chance of getting past committee.
0% chance of being enacted.

Only 11% of bills made it past committee and only about 3% were enacted in 2011–2013. [show factors | methodology]

Cosponsors
42 cosponsors (33D, 9R) (show)
Committees

House Energy and Commerce

Health

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


4/9/2013--Introduced.
Scleroderma Research and Awareness Act of 2013 - Amends the Public Health Service Act to authorize the Director of the National Institutes of Health (NIH) to expand, intensify, and coordinate NIH activities relating to scleroderma, with particular emphasis on:
(1) research focused on the etiology of scleroderma and the development of new treatment options;
(2) clinical research to evaluate new treatments options; and
(3) basic research on the relationship between scleroderma and secondary conditions, such as pulmonary hypertension, gastroparesis, Raynaud's phenomenon, and Sjogren's Syndrome.
Authorizes the Secretary of Health and Human Services (HHS) to carry out an educational campaign to increase public awareness of scleroderma. Permits print, video, and web-based materials distributed through this campaign to include: (1) basic information on scleroderma and its symptoms; and (2) information on the incidence and prevalence of scleroderma, diseases and conditions affiliated with scleroderma, or the importance of early diagnosis and treatment of scleroderma.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 1429 with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus